期刊文献+

注射用亚锡替曲膦的制备及处方设计 被引量:3

Optimized Formulation of Tetrofosmin and Stannous Chloride for Injection Using Orthogonal Design
下载PDF
导出
摘要 目的探讨注射用亚锡替曲膦的处方。方法以放射化学纯度为指标,选取替曲膦用量、氯化亚锡用量、制剂pH值和氮气保护时间四个因素,每个因素选取三个水平,选用L9(34)表进行正交实验,对注射用亚锡替曲膦的处方进行筛选。结果四个因素中对评估指数的影响大小依次为制剂pH值>氮气保护时间>氯化亚锡用量>替曲膦用量。按照优化处方进行复核实验表明,注射用亚锡替曲膦的放射化学纯度为96.1%,且制剂性质稳定,符合2005年版药典要求。结论本处方工艺稳定,具有良好的应用前景。  OBJECTIVE To study the new preparation of tetrofosmin(TF) and stannous chloride for injection.METHODS The formulation of tetrofosmin and stannous chloride for injection was optimized using orthogonal design with radiochemical purity(RCP%).Four factors,including TF,SnCl2,pH and the time of N2 protect,and three levels for each factor that may affect the formulation of kit were selected and arranged in a L9(34)orthogonal experimental table. RESULTS The four factor affected the evaluating indicator(EI%) differently.PH behaved as the maximum,followed N2 protect time and SnCl2,TF behaved as the minimum.The orthogonal experiment was checked up,and the result indicated chat RCP% were 96.1%.The quality of the kit stability was complied with the Ch.P.2005.CONCLUSION The preparation procedure is good and reproducible.
出处 《中国现代应用药学》 CAS CSCD 北大核心 2007年第5期427-429,共3页 Chinese Journal of Modern Applied Pharmacy
关键词 注射用亚锡替曲膦 正交法 放射化学纯度 tetrofosmin and stannous chloride for injection orthogonal design radiochemical purity
  • 相关文献

参考文献3

  • 1HIGLEY B,SMITH F W,SMITH T,et al.Technetium-99m-1,2-bis[bis(2-ethoxyethyl) phosphino]ethane:Human biodistribution,dosimetry andsafety of a new myocardial perfusion imaging agent[J].Nucl Med 1993,34:30-38.
  • 2KELLY J D,FORSTER A M,HIGLEY B,et al.Technetium-99m-tetrofosmin as a new radiopharmaceutical for myocardial perfusion imaging[J].Nucl Med,1993,34:222-227.
  • 3OWUNWANNE A,PATEL M,SADEK S,et al.The handbook of radiopharmaceuticals(放射性药物手册)[M].Beijing:Atomic Energy Publish Company,2000:7-8.

同被引文献15

引证文献3

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部